2001Unpublished venueRequires access

Cytokines and growth factors in renal bone disease

Esther A. González, Kévin Martin

Open publisher page 0 citations

Abstract

Abstract Renal bone disease or renal osteodystrophy is a common complication of chronic renal failure and represents a spectrum of skeletal abnormalities ranging from high turnover states, such as osteitis fibrosa which is seen with secondary hyperparathyroidism, to states of low bone turnover which include osteomalacia and the increasingly common adynamic bone disease. While each of these abnormalities may be predominant in a specific patient, combinations of these patterns are commonly present. Histologically, osteitis fibrosa is characterized by increased bone turnover with increased osteoblast and osteoclast number and activity leading to increased bone formation and increased bone resorption. An additional feature of osteitis fibrosa, as the name implies, is the presence of endosteal and marrow fibrosis. In contrast, in adynamic bone disease, there is decreased bone turnover, with decreased number and activity of osteoblasts and osteoclasts.

About this research paper

What this paper is about

Abstract Renal bone disease or renal osteodystrophy is a common complication of chronic renal failure and represents a spectrum of skeletal abnormalities ranging from high turnover states, such as osteitis fibrosa which is seen with secondary hyperparathyroidism, to states of low bone turnover which include osteomalacia and the increasingly common adynamic bone disease. While each of these abnormalities may be predominant in a specific patient, combinations of these patterns are commonly present. Histologically, osteitis fibrosa is characterized by increased bone turnover with increased osteoblast and osteoclast number and activity leading to increased bone formation and increased bone resorption. An additional feature of osteitis fibrosa, as the name implies, is the presence of endosteal and marrow fibrosis. In contrast, in adynamic bone disease, there is decreased bone turnover, with decreased number and activity of osteoblasts and osteoclasts.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Abstract Renal bone disease or renal osteodystrophy is a common complication of chronic renal failure and represents a spectrum of skeletal abnormalities ranging from high turnover states, such as osteitis fibrosa which is seen with secondary hyperparathyroidism, to states of low bone turnover which include osteomalacia and the increasingly common adynamic bone disease. While each of these abnormalities may be predominant in a specific patient, combinations of these patterns are commonly present. Histologically, osteitis fibrosa is characterized by increased bone turnover with increased osteoblast and osteoclast number and activity leading to increased bone formation and increased bone resorption. An additional feature of osteitis fibrosa, as the name implies, is the presence of endosteal and marrow fibrosis. In contrast, in adynamic bone disease, there is decreased bone turnover, with decreased number and activity of osteoblasts and osteoclasts.

Key concepts: Renal osteodystrophy, Osteitis, Osteomalacia, Medicine, Bone remodeling, Osteitis fibrosa cystica, Osteoclast, Bone disease

Related papers

Back to paper searchBrowse research topicsOriginal source
Cytokines and growth factors in renal bone disease — Research Paper | ScholarLens